Innovating Works

TATAA

Desconocido
OPTOMICS: Combining optoacoustic imaging phenotypes and multi omics to advance diabetes healthcare TATAA BIOCENTER AB participó en un H2020: H2020-FETPROACT-2018-2020 Diabetes has emerged as a global pandemic affecting more than 420 million people worldwide, a number expected to further rise in the next de...
2020-12-16 - 2026-12-31 | Financiado
CORONADX: Three Rapid Diagnostic tests Point of Care for COVID 19 CoronaThree Rapid Diagnostic tests Point... TATAA BIOCENTER AB participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020 On 30th January 2020 WHO declared a global health emergency for the outbreak of the 2019 novel Coronavirus (COVID-19, or 2019-nCoV) that ori...
2020-04-08 - 2023-09-30 | Financiado
PainFACT: Molecular Mechanisms Associating Chronic Pain with Fatigue Affective Disorders Cardiovascular Dise... Chronic pain (CP) is the leading cause of disability, and is strongly associated with fatigue, anxiety and depression ─ also major contribut...
2019-11-22 - 2025-12-31 | Financiado
PITBUL: Point of Care implementation of TB testing with ultra fast Local Heating PCR TATAA BIOCENTER AB participó en un H2020: H2020-NMBP-2016-2017 The overall goal of this project is to bring the unique, ultra-fast Local Heating PCR technology and its current lab-proven prototype instru...
2017-11-09 - 2020-11-30 | Financiado
ELBA: European Liquid Biopsies Academy Towards widespread clinical application of blood based diagnosti... TATAA BIOCENTER AB participó en un H2020: H2020-MSCA-ITN-2017 Liquid biopsies have been heralded as a game changer in cancer management, with blood tests offering a minimally invasive, safe, and sensiti...
2017-08-30 - 2022-09-30 | Financiado
SPIDIA4P: SPIDIA for Personalized Medicine Standardisation of generic Pre analytical procedures for In vitro... TATAA BIOCENTER AB participó en un H2020: H2020-SC1-2016-2017 Molecular in vitro diagnostics and biomedical research have allowed great progress in personalised medicine but further progress is limited...
2016-11-30 - 2021-06-30 | Financiado
SMARTDIAGNOS: Next generation sepsis diagnosis TATAA BIOCENTER AB participó en un H2020: H2020-ICT-2015 Sepsis is a potentially fatal condition that arises when the body’s response to an infection damages its own tissues and organs. It is mainl...
2015-12-09 - 2020-01-31 | Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... TATAA BIOCENTER AB participó en un FP6: Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
2015-01-01 - 2019-12-31 | Financiado
EPITRAIN: Epigenetic Training Network Innovative techniques and models to understand epigenetic regulation i... TATAA BIOCENTER AB participó en un FP7: "Despite the past century witnessing considerable advances in our understanding of genetics, the success of genome-wide association studies...
Financiado
CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... TATAA BIOCENTER AB participó en un FP7: Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
Financiado
LabOnFoil: Laboratory Skin Patches and SmartCards based on foils and compatible with a smartphone TATAA BIOCENTER AB participó en un FP7: Conventional analytical methods often require a large sample volume and complicated time-consuming protocols. The objective of this project...
Financiado
EDU-GLIA: Innovative Techniques and Models to Study Glia Neuron Interactions TATAA BIOCENTER AB participó en un FP7: It became evident over the last 20 years that glial cells are involved in virtually every aspect of nervous system function. Neurons and gli...
Financiado
HOMAGE: Heart OMics in AGEing TATAA BIOCENTER AB participó en un FP7: As more people survive into old age, the prevalence of heart failure (HF), one of the most common and debilitating diseases in older people,...
Financiado
EURHEALTHAGEING: European ResearcH on DevElopmentAL BirtH and Genetic Determinants of Ageing TATAA BIOCENTER AB participó en un FP7: Developmental plasticity modulated by epigenetic processes such as methylation and post-translational modifications is influenced by early l...
Financiado
SPIDIA: Standardisation and improvement of generic pre analytical tools and procedures for in vitro diagnost... TATAA BIOCENTER AB participó en un FP7: In vitro diagnostics have allowed a great deal of progress in medicine but are limited by two factors: (a) the lack of guidelines in collect...
Financiado
CD-MEDICS: Coeliac Disease Management Monitoring and Diagnosis using Biosensors and an Integrated Chip Syst... TATAA BIOCENTER AB participó en un FP7: The overall concept of the CD-MEDICS IP is to develop a technology platform for point-of-care diagnostics, capable of simultaneous genomic a...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.